ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,516.28
0.13%
US Tech 100
19,502.00
0.12%
Dow Jones
39,330.38
0.00%
Brent Oil
86.415
-0.03%
Bitcoin
60,477.00
-2.50%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Acurx Pharmaceuticals Inc (ACXP)

  7. Acurx Pharmaceuticals Inc (ACXP) News

ACXP

Acurx Pharmaceuticals (ACXP)

Acurx Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACXP
DateTimeSourceHeadlineSymbolCompany
06/18/20244:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACXPAcurx Pharmaceuticals Inc
06/18/20244:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACXPAcurx Pharmaceuticals Inc
06/17/20244:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACXPAcurx Pharmaceuticals Inc
06/06/20249:30AMGlobeNewswire Inc.New to The Street Announces Episode 576, Four Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, Thursday, June 6, 2024, at 9:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
05/15/20249:00AMPR Newswire (US)Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile InfectionNASDAQ:ACXPAcurx Pharmaceuticals Inc
05/15/20247:50AMIH Market NewsU.S. Index Futures Flat Ahead of April CPI Data Release, Oil Prices DropNASDAQ:ACXPAcurx Pharmaceuticals Inc
05/15/20247:13AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACXPAcurx Pharmaceuticals Inc
05/15/20247:00AMPR Newswire (US)Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business UpdateNASDAQ:ACXPAcurx Pharmaceuticals Inc
05/14/20244:05PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACXPAcurx Pharmaceuticals Inc
05/02/20247:00AMPR Newswire (US)Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific ConferenceNASDAQ:ACXPAcurx Pharmaceuticals Inc
04/25/202410:12AMPR Newswire (US)Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific ConferenceNASDAQ:ACXPAcurx Pharmaceuticals Inc
04/23/202410:57AMPR Newswire (US)Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business UpdateNASDAQ:ACXPAcurx Pharmaceuticals Inc
03/19/20247:33AMIH Market NewsUnilever Initiates Ice Cream Division Spin-Off and Announces Job Cuts; Berkshire Ramps Up Share Buyback Efforts, and MoreNASDAQ:ACXPAcurx Pharmaceuticals Inc
03/18/20247:12AMIH Market NewsAnticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See UpticksNASDAQ:ACXPAcurx Pharmaceuticals Inc
03/18/20247:01AMPR Newswire (US)Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business UpdateNASDAQ:ACXPAcurx Pharmaceuticals Inc
03/04/20247:01AMPR Newswire (US)Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 Conference Call and Provide Business UpdateNASDAQ:ACXPAcurx Pharmaceuticals Inc
02/27/20247:01AMPR Newswire (US)Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU DevelopmentNASDAQ:ACXPAcurx Pharmaceuticals Inc
02/23/20249:30AMGlobeNewswire Inc.New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised SeriesNASDAQ:ACXPAcurx Pharmaceuticals Inc
02/16/20249:30AMGlobeNewswire Inc.New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
02/02/20249:30AMGlobeNewswire Inc.New to The Street Announces its 553rd Episode TV Line Up, Featuring Five Corporate Guests, Airing on the FOX Business Network, Monday, February 5, 2024, 10:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
02/01/20249:33AMGlobeNewswire Inc.New to The Street TV Announces Episode #552 with its Five Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, February 1, 2024, at 9:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
01/29/20247:00AMPR Newswire (US)Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI PatientsNASDAQ:ACXPAcurx Pharmaceuticals Inc
01/26/202410:55AMGlobeNewswire Inc.New to The Street Announces Episode 551, Five Corporate Interviews, Airing on the FOX Business Network, Monday, January 29, 2024, at 10:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
01/23/20247:01AMPR Newswire (US)Acurx Pharmaceuticals to Present at the Microcap Conference, January 31, 2024 - February 1, 2024NASDAQ:ACXPAcurx Pharmaceuticals Inc
01/22/20246:15AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACXPAcurx Pharmaceuticals Inc
01/19/20249:30AMGlobeNewswire Inc.New to The Street Airs on the FOX Business Network, Episode 550, Featuring Six Corporate Interviews, Broadcast Monday, January 22, 2024, at 10:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
01/17/20247:01AMPR Newswire (US)Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI PatientsNASDAQ:ACXPAcurx Pharmaceuticals Inc
01/05/20249:30AMGlobeNewswire Inc.New to The Street Announces its Four Corporate Interviews, Episode 543, Airing on the Fox Business Network, Monday, January 8, 2024, at 10:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
01/03/20248:00AMPR Newswire (US)Acurx to present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ACXPAcurx Pharmaceuticals Inc
12/11/20237:01AMPR Newswire (US)Acurx Announces Positive Phase 2b Results Showing 100% of Patients Who Had Clinical Cure with Ibezapolstat Also Had Sustained Clinical CureNASDAQ:ACXPAcurx Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACXP

Your Recent History

BIT
P20HQ2
NLBNPIT20HQ2 20351221 23...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved